방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 염증성 장질환 설문지× | EORTC QLQ-C30× | |
|---|---|---|
| 분야 | 건강 결과 | 건강 결과 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1994 | 1993 |
| 창시자≠ | Elena J. Irvine et al. | Nico Aaronson et al. |
| 유형 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 원전≠ | Guyonnet, S., Dupont, C., Mouterde, O., Chouraqui, J. P., Darmaun, D., & Goulet, O. (2001). Placebo-controlled trial of saccharomyces boulardii in gastroenteritis. Pediatrics, 107(2), E27. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 별칭 | IBDQ, IBD Questionnaire, Inflammatory Bowel Disease QoL | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 관련≠ | 4 | 5 |
| 요약≠ | The IBDQ is a disease-specific quality of life measure for inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Developed by Elena Irvine and colleagues in 1994, this 32-item questionnaire measures how IBD affects bowel function, systemic symptoms, emotional well-being, and social functioning. It is the most widely used quality-of-life instrument in IBD research and clinical practice. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate데이터셋 ↗ |
|
|